PSNews - The Drug Administration of Vietnam (DAV) under the Ministry of Health on February 17 granted certificates of registration for conditional circulation to three COVID-19 treatment drugs containing the active ingredient Molnupiravir.
Health professionals of the Ministry of Health are due to meet on January 5 to consider licensing local pharmaceutical companies that produce Molnupiravir for COVID-19 treatment.
PSNews - Recently, the Ministry of Health announced that, domestic drug manufacturers will sponsor the first batch of 16,000 doses of Molnupiravir for a pilot programme of controlled treatment of COVID-19 patients at home in HCM City.
A batch of 300,000 Molnupiravir pills used to treat COVID-19 patients is projected to arrive in Ho Chi Minh City, the nation's current largest coronavirus hotspot, on August 23, according to newswire Zing News.